232 related articles for article (PubMed ID: 26377682)
61. Genomic duplication of PTPN11 is an uncommon cause of Noonan syndrome.
Graham JM; Kramer N; Bejjani BA; Thiel CT; Carta C; Neri G; Tartaglia M; Zenker M
Am J Med Genet A; 2009 Oct; 149A(10):2122-8. PubMed ID: 19760651
[TBL] [Abstract][Full Text] [Related]
62. [Multiple granular cell tumours in a patient with Noonan's syndrome and juvenile myelomonocytic leukaemia].
Castagna J; Clerc J; Dupond AS; Laresche C
Ann Dermatol Venereol; 2017 Nov; 144(11):705-711. PubMed ID: 28728859
[TBL] [Abstract][Full Text] [Related]
63. The relationship between clinical severity of Noonan's syndrome and growth, growth hormone (GH) secretion and response to GH treatment.
Noordam K; van der Burgt I; Brunner HG; Otten BJ
J Pediatr Endocrinol Metab; 2002 Feb; 15(2):175-80. PubMed ID: 11874182
[TBL] [Abstract][Full Text] [Related]
64. Analysis of the PTPN11 gene in idiopathic short stature children and Noonan syndrome patients.
Ferreira LV; Souza SC; Montenegro LR; Malaquias AC; Arnhold IJ; Mendonca BB; Jorge AA
Clin Endocrinol (Oxf); 2008 Sep; 69(3):426-31. PubMed ID: 18331608
[TBL] [Abstract][Full Text] [Related]
65. Autoimmune liver disease in Noonan Syndrome.
Loddo I; Romano C; Cutrupi MC; Sciveres M; Riva S; Salpietro A; Ferraù V; Gallizzi R; Briuglia S
Eur J Med Genet; 2015 Mar; 58(3):188-90. PubMed ID: 25595571
[TBL] [Abstract][Full Text] [Related]
66. Paternally Inherited Noonan Syndrome Caused by a
Han JY; Park J
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674380
[TBL] [Abstract][Full Text] [Related]
67. Growth response, near-adult height, and patterns of growth and puberty in patients with noonan syndrome treated with growth hormone.
Romano AA; Dana K; Bakker B; Davis DA; Hunold JJ; Jacobs J; Lippe B
J Clin Endocrinol Metab; 2009 Jul; 94(7):2338-44. PubMed ID: 19401366
[TBL] [Abstract][Full Text] [Related]
68. A case report of Noonan syndrome-like disorder with loose anagen hair 2 treated with recombinant human growth hormone.
Zhou P; Zhu L; Fan Q; Liu Y; Zhang T; Yang T; Chen J; Cheng Q; Li T; Chen L
Am J Med Genet A; 2020 Aug; 182(8):1967-1971. PubMed ID: 32476286
[TBL] [Abstract][Full Text] [Related]
69. PTPN11 Gain-of-Function Mutations Affect the Developing Human Brain, Memory, and Attention.
Johnson EM; Ishak AD; Naylor PE; Stevenson DA; Reiss AL; Green T
Cereb Cortex; 2019 Jul; 29(7):2915-2923. PubMed ID: 30059958
[TBL] [Abstract][Full Text] [Related]
70. Genotype-phenotype association by echocardiography offers incremental value in patients with Noonan Syndrome with Multiple Lentigines.
Kauffman H; Ahrens-Nicklas RC; Calderon-Anyosa RJC; Ritter AL; Lin KY; Rossano JW; Quartermain MD; Banerjee A
Pediatr Res; 2021 Aug; 90(2):444-451. PubMed ID: 33318624
[TBL] [Abstract][Full Text] [Related]
71. Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome.
Lee ST; Ki CS; Lee HJ
Clin Genet; 2007 Aug; 72(2):150-5. PubMed ID: 17661820
[TBL] [Abstract][Full Text] [Related]
72. Molecular characterization of Chilean patients with a clinical diagnosis of Noonan syndrome.
Rodríguez FA; Unanue N; Hernández MI; Heath KE; Cassorla F
J Pediatr Endocrinol Metab; 2014 Mar; 27(3-4):305-9. PubMed ID: 24150203
[TBL] [Abstract][Full Text] [Related]
73. Acute lymphoblastic leukemia in the context of RASopathies.
Cavé H; Caye A; Strullu M; Aladjidi N; Vignal C; Ferster A; Méchinaud F; Domenech C; Pierri F; Contet A; Cacheux V; Irving J; Kratz C; Clavel J; Verloes A
Eur J Med Genet; 2016 Mar; 59(3):173-8. PubMed ID: 26855057
[TBL] [Abstract][Full Text] [Related]
74. Noonan syndrome: Severe phenotype and PTPN11 mutations.
Carrasco Salas P; Gómez-Molina G; Carreto-Alba P; Granell-Escobar R; Vázquez-Rico I; León-Justel A
Med Clin (Barc); 2019 Jan; 152(2):62-64. PubMed ID: 29703613
[TBL] [Abstract][Full Text] [Related]
75. Duplication of chromosome band 12q24.11q24.23 results in apparent Noonan syndrome.
Shchelochkov OA; Patel A; Weissenberger GM; Chinault AC; Wiszniewska J; Fernandes PH; Eng C; Kukolich MK; Sutton VR
Am J Med Genet A; 2008 Apr; 146A(8):1042-8. PubMed ID: 18348260
[TBL] [Abstract][Full Text] [Related]
76. Malignancy in Noonan syndrome and related disorders.
Smpokou P; Zand DJ; Rosenbaum KN; Summar ML
Clin Genet; 2015 Dec; 88(6):516-22. PubMed ID: 25683281
[TBL] [Abstract][Full Text] [Related]
77. Vascular endothelial growth factor (VEGF) levels in short, GH treated children: a distinct pattern of VEGF-C in Noonan syndrome.
Fuchs S; Gat-Yablonski G; Shtaif B; Lazar L; Phillip M; Lebenthal Y
J Endocrinol Invest; 2015 Apr; 38(4):399-406. PubMed ID: 25344824
[TBL] [Abstract][Full Text] [Related]
78. Concurrence of anorexia nervosa and Noonan syndrome.
Arvaniti A; Samakouri M; Keskeridou F; Veletza S
Eur Eat Disord Rev; 2014 Jan; 22(1):83-5. PubMed ID: 24089313
[TBL] [Abstract][Full Text] [Related]
79. Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia.
Niihori T; Aoki Y; Ohashi H; Kurosawa K; Kondoh T; Ishikiriyama S; Kawame H; Kamasaki H; Yamanaka T; Takada F; Nishio K; Sakurai M; Tamai H; Nagashima T; Suzuki Y; Kure S; Fujii K; Imaizumi M; Matsubara Y
J Hum Genet; 2005; 50(4):192-202. PubMed ID: 15834506
[TBL] [Abstract][Full Text] [Related]
80. Mutation in NRAS in familial Noonan syndrome--case report and review of the literature.
Ekvall S; Wilbe M; Dahlgren J; Legius E; van Haeringen A; Westphal O; Annerén G; Bondeson ML
BMC Med Genet; 2015 Oct; 16():95. PubMed ID: 26467218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
